The Official Medicare Set Aside Blog And Information Resource

Announcing: MEDVAL Rx for Self-Administered MSAs

Medicare Set-Aside Blog, Medicare Set-Asides, MSA Administration, Rx/Pharmacy on April 23, 2020
Posted by Jean S. Goldstein, JD, CMSP

MEDVAL is pleased to announce its new Post-Settlement Administration Services offered through MEDVAL Rx. These services are available to individuals who have funds in a Medicare-Set-Aside (MSA) account to pay for future prescription expenses.  MEDVAL Rx historically limited these services to MSAs that were professionally administered, but all self-administered MSA accounts, regardless of which vendor […] Continue

Comment Period Closed for Section 111 Civil Money Penalties Proposed Rule

CMS, Mandatory Insurer Reporting, MSP News on April 22, 2020
Posted by Jean S. Goldstein, JD, CMSP

On Monday, the comment period for the Centers for Medicare & Medicaid’s (CMS) Section 111 Civil Money Penalties (CMPs) proposed rule closed.  Entities that are responsible for complying with Section 111 reporting, and subsequently which may be subject to CMPs are referred to as Responsible Reporting Entities (RREs).  These entities must provide specific data on […] Continue

COVID-19: Impact on the FDA Pipeline

FDA, Medicare Set-Aside Blog, Rx/Pharmacy on April 15, 2020
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

The impact of COVID-19 has undoubtedly been profound, but some of its effects are less obvious than others. One of the impacts associated with the COVID-19 pandemic that may not have hit home yet for many is the likely effect on the pipeline of new drug approvals through the FDA. The pandemic will likely produce […] Continue

Significant Price Changes for Meloxicam & Benefits to Your WCMSAs

Medicare Set-Aside Blog, MSAs, Rx/Pharmacy on April 2, 2020
Posted by Jean S. Goldstein, JD, CMSP

Mobic (meloxicam) is a nonsteroidal anti-inflammatory drug (NSAID) commonly seen in workers’ compensation claims.  It is most frequently prescribed to treat osteoarthritis (OA) starting at doses of 7.5 mg and may be increased to 15 mg daily to reduce pain, joint swelling, and stiffness in joints. Recently, the average wholesale price of this medication dropped […] Continue

Will the Expansion of Telehealth Services Lead to More Conditional Payments?

CMS, Conditional Payments, Medicare Set-Aside Blog, Telehealth on March 30, 2020
Posted by Jean S. Goldstein, JD, CMSP

In 2019, Medicare started covering some virtual care services. The services covered included brief communications and Virtual Check-Ins (short patient-initiated communications with a healthcare practitioner) along with E-visits (which are non-face-to-face patient-initiated communications through an online patient portal). However, telehealth services have generally not been covered. Historically, for telehealth services to be covered, certain circumstances […] Continue